Insulet Corporation (GOV.F)

166,05 -4,65 (-2,72%) Ab 08:05AM CEST. Markt geöffnet.

Insulet Corporation

100 Nagog Park
Acton, MA 01720
United States
978 600 7000
https://www.insulet.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 3.000

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Dr. James R. Hollingshead Ph.D.	President, CEO & Director	2,67M	N/A	1963
Ms. Lauren Budden	Group VP, Chief Accounting Officer & Controller	737,48k	N/A	1975
Mr. Mark Field	Senior VP & CTO	886,17k	N/A	1971
Mr. John Wodick Kapples	Senior VP & General Counsel	950,35k	N/A	1960
Ms. Shacey Petrovic	Director & Advisor	26,54k	N/A	1973
Mr. Eric Benjamin	Executive VP, Chief Product & Customer Experience Officer	1,06M	N/A	1983
Ms. Ana Maria Chadwick	Executive VP, CFO & Treasurer	N/A	N/A	1972
Mr. Prem Singh	Senior Vice President of Global Operations	N/A	N/A	1977
Ms. Deborah R. Gordon CPA	Vice President of Investor Relations	N/A	N/A	1971
Ms. Laetitia Cousin	Senior VP of Regulatory Affairs, Quality Assurance & Compliance	N/A	N/A	1976

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Corporate Governance

Insulet Corporations ISS Governance QualityScore, Stand 1. Mai 2024, lautet 9. Die grundlegenden Scores sind Audit: 7, Vorstand: 8, Shareholderrechte: 10, Kompensation: 9.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.